Atrys Health SL (ATRY) - Total Liabilities

Latest as of December 2025: €342.08 Million EUR ≈ $399.93 Million USD

Based on the latest financial reports, Atrys Health SL (ATRY) has total liabilities worth €342.08 Million EUR (≈ $399.93 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Atrys Health SL - Total Liabilities Trend (2012–2025)

This chart illustrates how Atrys Health SL's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Atrys Health SL to evaluate short-term liquidity relative to the company's equity base.

Atrys Health SL Competitors by Total Liabilities

The table below lists competitors of Atrys Health SL ranked by their total liabilities.

Company	Country	Total Liabilities
Skue Sparebank OL:SKUE	Norway	Nkr23.76 Billion
Frauenthal Holding AG VI:FKA	Austria	€204.49 Million
Eaton Vance Municipal Income Term Closed Fund NYSE:ETX	USA	$7.96 Million
GAEC Educacao SA SA:ANIM3	Brazil	R$7.63 Billion
Great China Metal Industry Co Ltd TW:9905	Taiwan	NT$3.49 Billion
HomeToGo SE XETRA:HTG	Germany	€387.58 Million
Nova Lifestyle I NASDAQ:NVFY	USA	$4.70 Million
Europap Tezol Kagit Sanayi Ve Ticaret AS IS:TEZOL	Turkey	TL1.56 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Atrys Health SL's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ATRY stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Atrys Health SL's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Atrys Health SL (2012–2025)

The table below shows the annual total liabilities of Atrys Health SL from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	€342.08 Million ≈ $399.93 Million	+3.36%
2024-12-31	€330.95 Million ≈ $386.92 Million	-2.41%
2023-12-31	€339.12 Million ≈ $396.47 Million	-7.77%
2022-12-31	€367.71 Million ≈ $429.89 Million	+26.08%
2021-12-31	€291.65 Million ≈ $340.97 Million	+190.35%
2020-12-31	€100.45 Million ≈ $117.43 Million	+108.88%
2019-12-31	€48.09 Million ≈ $56.22 Million	+76.47%
2018-12-31	€27.25 Million ≈ $31.86 Million	+61.25%
2017-12-31	€16.90 Million ≈ $19.76 Million	+3.64%
2016-12-31	€16.31 Million ≈ $19.06 Million	+13.27%
2015-12-31	€14.40 Million ≈ $16.83 Million	+14.17%
2014-12-31	€12.61 Million ≈ $14.74 Million	+2.90%
2013-12-31	€12.25 Million ≈ $14.33 Million	+0.14%
2012-12-31	€12.24 Million ≈ $14.31 Million	--

About Atrys Health SL

MC:ATRY Spain Biotechnology

Market Cap

$234.76 Million

€200.80 Million EUR

Market Cap Rank

#16587 Global

#109 in Spain

Share Price

€2.65

Change (1 day)

-2.40%

52-Week Range

€2.51 - €3.51

All Time High

€11.20